Alector, Inc. (ALEC) vs Protalix BioTherapeutics, Inc. (PLX)
Alector, Inc. and Protalix BioTherapeutics, Inc. are both Biotechnology companies. Alector, Inc. and Protalix BioTherapeutics, Inc. are of similar size ($221.6M and $214.4M). Alector, Inc. has negative trailing earnings, so its P/E is not meaningful; Protalix BioTherapeutics, Inc. trades at 11.3×. Protalix BioTherapeutics, Inc. grew revenue faster over the last twelve months: 30.1% against −82.9%. Protalix BioTherapeutics, Inc. has the higher net margin (23.5% vs −850.1%) and the higher return on invested capital (48.5% vs 0.00%). Across the 17 metrics below, Protalix BioTherapeutics, Inc. leads on 11 and Alector, Inc. on 6.
Valuation
Profitability
| Metric | ALEC | PLX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 69.20% | 65.16% |
| Operating margin | (912.40%) | 28.89% | 0.00% |
| Net margin | (850.13%) | 23.50% | 0.00% |
| Free cash flow margin | (1,142.55%) | 9.51% | 0.00% |
| Return on equity | (385.11%) | 31.23% | (57.72%) |
| Return on assets | (42.15%) | 20.07% | (49.22%) |
| Return on invested capital | 0.00% | 48.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack